Aristo Bio-Tech & Lifescience Complete Financial Statements
ARISTO • Review detailed financials to uncover trends, confirm thesis & journal trades
10 Years of Data
2025 - 2016
Complete Financial Data Export
Export complete financial statements for Aristo Bio-Tech & Lifescience (ARISTO).
Downloads include all available records across all periods.
For market performance, see the
ARISTO stock price today
.
Profitability Ratios
Net Profit Margin
1.25%
2025 data
EBITDA Margin
3.13%
2025 data
Operating Margin
3.00%
2025 data
Return on Assets
2.84%
2025 data
Return on Equity
10.81%
2025 data
Balance Sheet Ratios
Current Ratio
14.50
2025 data
Debt to Equity
3.81
2025 data
Equity Ratio
26.24%
2025 data
Asset Turnover
2.26
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+11.0%
Year-over-Year
Equity Growth
+8.8%
Year-over-Year
Liabilities Growth
+11.0%
Year-over-Year
Operating Cash Flow Growth
+25.0%
Year-over-Year
Investing Cash Flow Growth
+28.6%
Year-over-Year
Financing Cash Flow Growth
-100.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 319 | 245 | 218 | 166 | 167 | 201 | 202 | 272 | 161 | 58 |
| Expenses | 0 | 309 | 237 | 209 | 161 | 163 | 197 | 195 | 264 | 158 | 56 |
| EBITDA | 0 | 10 | 9 | 9 | 5 | 4 | 5 | 7 | 8 | 4 | 1 |
| Operating Profit Margin % | 0.00% | 3.00% | 3.00% | 4.00% | 3.00% | 3.00% | 2.00% | 3.00% | 3.00% | 2.00% | 2.00% |
| Depreciation | 0 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Interest | 0 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 1 | 1 |
| Profit Before Tax | 0 | 6 | 5 | 5 | 2 | 2 | 1 | 4 | 6 | 3 | 1 |
| Tax | 0 | 1 | 2 | 1 | 1 | 0 | 0 | 1 | 2 | 1 | 0 |
| Net Profit | 0 | 4 | 4 | 4 | 1 | 1 | 1 | 3 | 4 | 2 | 0 |
| Earnings Per Share (₹) | 0.00 | 5.97 | 5.72 | 6.72 | 2.87 | 2.15 | 2.02 | 5.66 | 37.41 | 18.53 | 3.98 |
Related Pages for Aristo Bio-Tech & Lifescience
Additional stock information and data for ARISTO
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Total Assets | 141 | 127 | 100 | 77 | 81 | 88 | 91 | 89 | 87 | 27 |
| Current Assets | 116 | 105 | 83 | 63 | 69 | 77 | 81 | 81 | 84 | 25 |
| Fixed Assets | 24 | 22 | 16 | 14 | 12 | 8 | 8 | 3 | 2 | 2 |
| Capital Work in Progress | 0 | 0 | 1 | 0 | 0 | 3 | 2 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 117 | 106 | 83 | 63 | 69 | 77 | 81 | 86 | 85 | 25 |
| LIABILITIES | ||||||||||
| Total Liabilities | 141 | 127 | 100 | 77 | 81 | 88 | 91 | 89 | 87 | 27 |
| Current Liabilities | 8 | 10 | 10 | 11 | 12 | 11 | 7 | 11 | 5 | 0 |
| Non-Current Liabilities | ||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||
| Total Equity | 37 | 34 | 30 | 15 | 13 | 12 | 11 | 9 | 5 | 3 |
| Share Capital | 7 | 7 | 7 | 5 | 5 | 5 | 5 | 1 | 1 | 1 |
| Reserves & Surplus | 31 | 27 | 23 | 10 | 8 | 7 | 6 | 8 | 4 | 2 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 10 | 8 | -3 | 7 | 2 | 1 | 8 | 1 | -4 |
| Investing Activities | -5 | -7 | -4 | -3 | -2 | -2 | -2 | -5 | 0 |
| Financing Activities | -4 | -2 | 8 | -3 | -1 | 1 | -6 | 4 | 4 |
| Net Cash Flow | 1 | -1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |